Myriad Genetics
MYGN • NASDAQ • Stock Fundamentals
Myriad Genetics is a medical - diagnostics & research company in the healthcare sector trading on NASDAQ, led by CEO Samraat S. Raha, with a market cap of $437.3M.
Market Cap$437.3M
Employees2.7K
CEOSamraat S. Raha
CountryUnited States of America
Healthcare
Medical - Diagnostics & Research
Most Recent EarningsMay 5, 2026 · 1 month 9 days agoQ1 2026
View reportNext EarningsAug 4, 2026 · in 2 monthsAfter Market Close · Q2 2026
Financials
Based on Q1 2026 filing
Myriad Genetics FAQ
Common questions about Myriad Genetics
Myriad Genetics (MYGN) has a market capitalization of $437.3M and trades on NASDAQ.
Myriad Genetics has approximately 2,700 employees.